<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Proc Natl Acad Sci U S A</journal-id>
<journal-id journal-id-type="iso-abbrev">Proc. Natl. Acad. Sci. U.S.A</journal-id>
<journal-id journal-id-type="hwp">pnas</journal-id>
<journal-id journal-id-type="pmc">pnas</journal-id>
<journal-id journal-id-type="publisher-id">PNAS</journal-id>
<journal-title-group>
<journal-title>Proceedings of the National Academy of Sciences of the United States of America</journal-title>
</journal-title-group>
<issn pub-type="ppub">0027-8424</issn>
<issn pub-type="epub">1091-6490</issn>
<publisher>
<publisher-name>National Academy of Sciences</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28223486</article-id>
<article-id pub-id-type="pmc">5347541</article-id>
<article-id pub-id-type="publisher-id">201616070</article-id>
<article-id pub-id-type="doi">10.1073/pnas.1616070114</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>PNAS Plus</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Biological Sciences</subject>
<subj-group>
<subject>Neuroscience</subject>
</subj-group>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Physical Sciences</subject>
<subj-group>
<subject>Environmental Sciences</subject>
</subj-group>
</subj-group>
<series-title>PNAS Plus</series-title>
</article-categories>
<title-group>
<article-title>Serum-borne bioactivity caused by pulmonary multiwalled carbon nanotubes induces neuroinflammation via blood–brain barrier impairment</article-title>
<alt-title alt-title-type="short">Blood–brain barrier impacts of nanotube exposure</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Aragon</surname>
<given-names>Mario J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Topper</surname>
<given-names>Lauren</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tyler</surname>
<given-names>Christina R.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sanchez</surname>
<given-names>Bethany</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zychowski</surname>
<given-names>Katherine</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Young</surname>
<given-names>Tamara</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Herbert</surname>
<given-names>Guy</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hall</surname>
<given-names>Pamela</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Erdely</surname>
<given-names>Aaron</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eye</surname>
<given-names>Tracy</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bishop</surname>
<given-names>Lindsey</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Saunders</surname>
<given-names>Samantha A.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Muldoon</surname>
<given-names>Pretal P.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ottens</surname>
<given-names>Andrew K.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Campen</surname>
<given-names>Matthew J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>1</sup>
</xref>
</contrib>
<aff id="aff1"><sup>a</sup>Department of Pharmaceutical Sciences, College of Pharmacy, <institution>University of New Mexico</institution>, Albuquerque, <addr-line>NM</addr-line> 87131;</aff>
<aff id="aff2"><sup>b</sup>Pathology and Physiology Research Branch, <institution>National Institute for Occupational Safety and Health</institution>, Morgantown, <addr-line>WV</addr-line> 26505;</aff>
<aff id="aff3"><sup>c</sup>Department of Anatomy and Neurobiology, School of Medicine, <institution>Virginia Commonwealth University</institution>, Richmond, VA <addr-line>23298</addr-line></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><sup>1</sup>To whom correspondence may be addressed. Email: <email>akottens@vcu.edu</email> or <email>mcampen@salud.unm.edu</email>.</corresp>
<fn fn-type="edited-by">
<p>Edited by Lawrence Steinman, Stanford University School of Medicine, Stanford, CA, and approved January 20, 2017 (received for review September 26, 2016)</p>
</fn>
<fn fn-type="con">
<p>Author contributions: M.J.A., A.E., A.K.O., and M.J.C. designed research; M.J.A., L.T., C.R.T., B.S., K.Z., T.Y., G.H., A.E., T.E., L.B., S.A.S., P.P.M., A.K.O., and M.J.C. performed research; P.H. contributed new reagents/analytic tools; M.J.A., L.T., C.R.T., B.S., K.Z., T.Y., G.H., T.E., L.B., S.A.S., P.P.M., A.K.O., and M.J.C. analyzed data; and M.J.A., C.R.T., P.H., A.E., A.K.O., and M.J.C. wrote the paper.</p>
</fn>
<fn fn-type="COI-statement">
<p>The authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>7</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>21</day>
<month>2</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>21</day>
<month>2</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>114</volume>
<issue>10</issue>
<fpage>E1968</fpage>
<lpage>E1976</lpage>
<permissions>
<license license-type="open-access">
<license-p>Freely available online through the PNAS open access option.</license-p>
</license>
</permissions>
<self-uri xlink:href="pnas.201616070.pdf" xlink:title="pdf"></self-uri>
<abstract abstract-type="executive-summary">
<title>Significance</title>
<p>Inhaled particulates, such as multiwalled carbon nanotubes, can induce neuroinflammatory outcomes. The present study shows that acute neuroinflammation is dependent on the impairment of blood-brain barrier function. Pharmacologic restoration of blood-brain barrier integrity prevented the neuroinflammatory responses to pulmonary multiwalled carbon nanotube exposure. Circulating factors, including possibly thrombospondin-1, recapitulate inflammatory responses in cultured cerebrovascular endothelial cells, suggesting a mechanism for indirect systemic effects of inhaled nanoparticles.</p>
</abstract>
<abstract>
<p>Pulmonary exposure to multiwalled carbon nanotubes (MWCNTs) causes indirect systemic inflammation through unknown pathways. MWCNTs translocate only minimally from the lungs into the systemic circulation, suggesting that extrapulmonary toxicity may be caused indirectly by lung-derived factors entering the circulation. To assess a role for MWCNT-induced circulating factors in driving neuroinflammatory outcomes, mice were acutely exposed to MWCNTs (10 or 40 µg/mouse) via oropharyngeal aspiration. At 4 h after MWCNT exposure, broad disruption of the blood-brain barrier (BBB) was observed across the capillary bed with the small molecule fluorescein, concomitant with reactive astrocytosis. However, pronounced BBB permeation was noted, with frank albumin leakage around larger vessels (&gt;10 µm), overlain by a dose-dependent astroglial scar-like formation and recruitment of phagocytic microglia. As affirmed by elevated inflammatory marker transcription, MWCNT-induced BBB disruption and neuroinflammation were abrogated by pretreatment with the rho kinase inhibitor fasudil. Serum from MWCNT-exposed mice induced expression of adhesion molecules in primary murine cerebrovascular endothelial cells and, in a wound-healing in vitro assay, impaired cell motility and cytokinesis. Serum thrombospondin-1 level was significantly increased after MWCNT exposure, and mice lacking the endogenous receptor CD36 were protected from the neuroinflammatory and BBB permeability effects of MWCNTs. In conclusion, acute pulmonary exposure to MWCNTs causes neuroinflammatory responses that are dependent on the disruption of BBB integrity.</p>
</abstract>
<kwd-group>
<kwd>nanoparticle</kwd>
<kwd>blood-brain barrier</kwd>
<kwd>microglia</kwd>
<kwd>thrombospondin-1</kwd>
<kwd>multiwalled carbon nanotube</kwd>
</kwd-group>
<funding-group>
<award-group id="gs1">
<funding-source id="sp1">HHS | CDC | National Institute for Occupational Safety and Health (NIOSH)<named-content content-type="funder-id">100000125</named-content></funding-source>
<award-id rid="sp1">R01 OH010828</award-id>
</award-group>
<award-group id="gs2">
<funding-source id="sp2">HHS | NIH | National Institute of General Medical Sciences (NIGMS)<named-content content-type="funder-id">100000057</named-content></funding-source>
<award-id rid="sp2">K12 GM088021</award-id>
</award-group>
<award-group id="gs3">
<funding-source id="sp3">HHS | NIH | National Institute of Environmental Health Sciences (NIEHS)<named-content content-type="funder-id">100000066</named-content></funding-source>
<award-id rid="sp3">R01 ES014639</award-id>
</award-group>
<award-group id="gs4">
<funding-source id="sp4">HHS | NIH | National Institute of Environmental Health Sciences (NIEHS)<named-content content-type="funder-id">100000066</named-content></funding-source>
<award-id rid="sp4">R21 ES023060</award-id>
</award-group>
<award-group id="gs5">
<funding-source id="sp5">HHS | NIH | National Heart, Lung, and Blood Institute (NHBLI)<named-content content-type="funder-id">100000050</named-content></funding-source>
<award-id rid="sp5">T32 HL007736</award-id>
</award-group>
<award-group id="gs6">
<funding-source id="sp6">HHS | CDC | National Institute for Occupational Safety and Health (NIOSH)<named-content content-type="funder-id">100000125</named-content></funding-source>
<award-id rid="sp6">NTRC 939ZXFL</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="9"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>